136 related articles for article (PubMed ID: 1665959)
21. Synergistic effects of acyclovir and 3, 19-isopropylideneandrographolide on herpes simplex virus wild types and drug-resistant strains.
Priengprom T; Ekalaksananan T; Kongyingyoes B; Suebsasana S; Aromdee C; Pientong C
BMC Complement Altern Med; 2015 Mar; 15():56. PubMed ID: 25879785
[TBL] [Abstract][Full Text] [Related]
22. Simplified test for detecting the resistance of herpes simplex virus to acyclovir.
Agut H; Aubin JT; Ingrand D; Blanc S; Clayton AL; Chantler SM; Huraux JM
J Med Virol; 1990 Jul; 31(3):209-14. PubMed ID: 2167944
[TBL] [Abstract][Full Text] [Related]
23. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
Saijo M; Suzutani T; Yoshida I
Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
[TBL] [Abstract][Full Text] [Related]
24. Ganciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: intraocular penetration and efficacy.
Castela N; Vermerie N; Chast F; Sauvageon-Martre H; Denis J; Godard V; Goldschmidt P; Pouliquen Y
J Ocul Pharmacol; 1994; 10(2):439-51. PubMed ID: 8083563
[TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus genome quantification in two patients who developed herpetic epithelial keratitis during treatment with antiglaucoma medications.
Deai T; Fukuda M; Hibino T; Higaki S; Hayashi K; Shimomura Y
Cornea; 2004 Mar; 23(2):125-8. PubMed ID: 15075880
[TBL] [Abstract][Full Text] [Related]
26. Potentiating effect of mizoribine on the anti-herpes virus activity of acyclovir.
Pancheva S; Dundarova D; Remichkova M
Z Naturforsch C J Biosci; 2002; 57(9-10):902-4. PubMed ID: 12440731
[TBL] [Abstract][Full Text] [Related]
27. Topical treatment with nerve growth factor in an animal model of herpetic keratitis.
Lambiase A; Coassin M; Costa N; Lauretti P; Micera A; Ghinelli E; Aloe L; Rama P; Bonini S
Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):121-7. PubMed ID: 17479276
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo evaluation of a novel antiherpetic flavonoid, 4'-phenylflavone, and its synergistic actions with acyclovir.
Hayashi K; Iinuma M; Sasaki K; Hayashi T
Arch Virol; 2012 Aug; 157(8):1489-98. PubMed ID: 22580497
[TBL] [Abstract][Full Text] [Related]
29. [Antiviral therapy adjustment in corneal recipients using antibody testing in the aqueous humor].
Robert PY; Liekfeld A; Ranger-Rogez S; Jaekel C; Pleyer U; Adenis JP; Hartmann C
J Fr Ophtalmol; 2003 Apr; 26(4):350-4. PubMed ID: 12843891
[TBL] [Abstract][Full Text] [Related]
30. Combined effect of acyclovir and amphotericin B on the replication of pseudorabies virus in BHK-21 cells.
Malewicz B; Momsen M; Jenkin HM
Antimicrob Agents Chemother; 1983 Jan; 23(1):119-24. PubMed ID: 6299180
[TBL] [Abstract][Full Text] [Related]
31. Combined anti-herpes virus activity of nucleoside analogs and interferon.
Taylor JL; Punda-Polic V; O'Brien WJ
Curr Eye Res; 1991; 10 Suppl():205-11. PubMed ID: 1650669
[TBL] [Abstract][Full Text] [Related]
32. Treatment of herpetic keratitis with acyclovir: benefits and problems.
Ohashi Y
Ophthalmologica; 1997; 211 Suppl 1():29-32. PubMed ID: 9065935
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.
Yao YF; Inoue Y; Kase T; Uchihori Y; Mori Y; Ohashi Y
Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S126-32. PubMed ID: 8871163
[TBL] [Abstract][Full Text] [Related]
34. Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in mice.
Lobe DC; Spector T; Ellis MN
Antiviral Res; 1991 Feb; 15(2):87-100. PubMed ID: 1650166
[TBL] [Abstract][Full Text] [Related]
35. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
[TBL] [Abstract][Full Text] [Related]
36. Acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty.
Sonkin PL; Baratz KH; Frothingham R; Cobo LM
Ophthalmology; 1992 Dec; 99(12):1805-8. PubMed ID: 1336155
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
[TBL] [Abstract][Full Text] [Related]
38. Combined effects of acyclovir and human interferon-alpha on herpes simplex virus replication in cultured neural cells.
Hanada N; Kido S; Kuzushima K; Goto Y; Rahman MM; Morishima T
J Med Virol; 1989 Sep; 29(1):7-12. PubMed ID: 2555447
[TBL] [Abstract][Full Text] [Related]
39. Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless mice.
Lee PH; Su MH; Kern ER; Higuchi WI
Pharm Res; 1992 Aug; 9(8):979-89. PubMed ID: 1329068
[TBL] [Abstract][Full Text] [Related]
40. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis.
Duan R; de Vries RD; van Dun JM; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2009 Nov; 200(9):1402-14. PubMed ID: 19795980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
